Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations

Journal of Neural Transmission

Volumn 62, Issue 3-4, 1985, Pages 171-207

  Clark, D ^a   Hjorth, S ^a   Carlsson, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,6,10B OCTAHYDRO 7 HYDROXYBENZO[F]QUINOLINE; BROMOCRIPTINE; DEXAMPHETAMINE; DOPAMINE AUTORECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; PRECLAMOL; RADIOISOTOPE; TALIPEXOLE; TERGURIDE;

BEHAVIOR; CENTRAL NERVOUS SYSTEM; DOPAMINE H 3; DRUG EFFICACY; DRUG INTERACTION; DRUG MECHANISM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW;

ANIMAL; ANTIPSYCHOTIC AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; COMPARATIVE STUDY; CORPUS STRIATUM; CYCLIC AMP; DEXTROAMPHETAMINE; DOPAMINE; HUMAN; ISOMERISM; LISURIDE; MODELS, NEUROLOGICAL; MOLECULAR CONFORMATION; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PIPERIDINES; PITUITARY GLAND, ANTERIOR; PROLACTIN; RATS; RECEPTORS, DOPAMINE; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T; SYNAPTOSOMES;

EID: 0021798089     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/BF01252236     Document Type: Review

References (72)

1. Studies on the interaction between the substantia nigra and the neostriatum
2. Drug-receptor interaction: Interaction of one or more drugs with one receptor system
3. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions
4. Effects of S-(+)-3-phenethyl-PP, a putative dopamine autoreceptor agonist with greater autoreceptor selectivity than 3-PPP enantiomers
5. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol
6. Simultaneous release of endogenous and3H-dopamine
7. How adaptive behaviour is produced: a perceptual-motivational alternative to response-reinforcement
8. The proportion of neurons in the rat neostriatum that project ot the substantia nigra demonstrated using horseradish peroxidase conjugated with wheatgerm agglutinin
9. Opiate reward mechanisms mapped by intracranial self administration
10. Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal
11. Dendritic release of dopamine in the substantia nigra
12. Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity. I. Review of the evidence
13. The use of dopamine agonists in the treatment of schizophrenia
14. Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic-receptors?
15. The role of forebrain dopamine systems in amphetamine-induced stereotyped behaviour in the rat
16. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity
17. Radioligand binding studies of agonist interactions with dopamine receptors
18. Catecholamines and schizophrenia
19. Discovery of the clinical use of neuroleptics
20. The anatomical basis for feedback and feedforward in the striatonigral system
21. Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy
22. The putative dopamine autoreceptor agonist B-HT 920 decreases dopamine cell firing and prolactin release in rat
23. Evidence for hetero-genous rotational responsiveness to apomorphine, 3-PPP and SKF 38393 in 6-hydroxydopamine-denervated rats
24. Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in rat corpus striatum
25. Behavioural actions of neuroleptics
26. Detection of homovanillic acid in vivo using microcomputer-controlled voltammetry: simultaneous monitoring of rat motor activity and striatal dopamine release
27. An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine
28. A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement
29. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates
30. The relationship between loss of dopamine nerve terminals, striatal3H-spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats
31. Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different?
32. Catecholamines, enkephalin and neurotensin in feeding and reward
33. Brain dopamine systems and behaviour
34. Structure-activity relationships of the butyrophenones and diphenylbutyl-piperidines
35. Temporal changes in catecholamines synthesis of rat forebrain structures after axotomy
36. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
37. The classification of drugs and drug receptors in isolated tissues
38. The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy
39. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems
40. Effects of thioridazine on apomorphine-elicited Stereotypic behavior and motor activity
41. Multiple dopamine receptors: Relevance of in vitro binding data of subclassification of binding sites
42. Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects
43. Effects of peripheral stimulation on the activity of neurons in the ventral tegmental area
44. From motivation to activation: functional interface between the limbic system and the motor system
45. Dopaminergic behaviour stereospecifically promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390
46. Endocrine profile of ergot alkaloids
47. The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor sensitivity are not additive in the rat
48. Potential locus and mechanism of blockade of conditioned avoidance responding by neuroleptics
49. Separate roles for nucleus accumbens and caudate in acquisition and performance of avoidance behaviour
50. Neuroleptic-induced acute dyskinesias in Rhesus monkeys
51. An analysis of chlorpromazine-induced suppression of the avoidance response
52. Dopamine receptors in the denervated striatum: Further supersensitivity by chronic haloperidol treatment
53. Neurochemistry of monoaminergic neurons in Parkinson's disease
54. Depletion of dopamine in the striatum as an experimental model of Parkinsonism: direct effects and adaptive mechanisms
55. Neurochemical and functional studies with EMD 23448, a novel dopamine agonist
56. Locus of action of antipsychotic drugs
57. Dopamine receptor binding in bovine intermediate lobe pituitary membranes
58. Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors
59. Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-Peroxidase transport degeneration procedure
60. Functional in vitro comparison of striatal pre- and postsynaptic dopamine receptors
61. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior
62. Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive
63. Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization
64. Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for autoregulation
65. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies
66. Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: Central dopamine receptor activity
67. Dopamine and depression. A review of recent evidence. II. Theoretical approaches
68. Catecholamine theories of reward: a critical review
69. Neuroleptics and operant behaviour: the anhedonia hypothesis